DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
van Schaik IN, Bril V, van Geloven N. et al
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol 2018;
17: 35-46 doi:10.1016/S1474-4422(17)30378-2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.